This 2017 observational study (Phytomedicine, PMID: 29157828) evaluated immune-related and adverse drug reactions (ADRs) to low versus high initial doses of Viscum album L. (European mistletoe) in cancer patients. Higher starting doses were associated with increased immune responses, including mild fever and local inflammation, which were indicative of the desired
